Skip to content
Tuesday, November 17, 2026
Lunar Wager Daily

Patients Coming Off Anti-Obesity Jabs Regain Pounds Far More Rapidly Compared to People Using Diet and Exercise

Image of pharmaceutical syringe and weighing machine
Obesity treatment involves ongoing approaches.

Fresh analysis suggests that patients who come off popular weight-loss injections like Wegovy and Mounjaro may regain shed pounds far faster than those who stop conventional diet and exercise programs.

Published data in a leading health publication demonstrates that while obese people frequently drop about a fifth of their body weight while on the medication, the weight returns at an estimated rate of nearly a kilo each month once they quit.

"Users purchasing these medications should be aware of the risk of fast weight regain when the medication ends," warns lead investigator Dr. Susan Jebb.

That rate of recovery implies a reversion to original mass in about a year and a half.

Comparing Treatments

The research, which reviewed dozens of trials involving thousands of participants, compared the effects of the injectable medications with older methods.

Researchers note that people who shed pounds through dieting generally have a less rapid weight regain—around 100 grams monthly—post-intervention.

The Reason for the Quick Rebound

Experts suggest the mechanism of the injections is key to understanding the heightened regain.

GLP-1 drugs copy a natural hormone called GLP-1, which moderates appetite.

"Long-term administration of GLP-1 concentrations several times higher than the body's typical production may cause the system to generate a reduced amount of its endogenous GLP-1, and could diminish sensitivity to its effects," noted Dr. Adam Collins, a dietetics specialist.

"Stopping of this hormone supplement means hunger is unsuppressed, making binge eating much more probable."

A Lifelong Issue?

Health authorities suggest the injections for individuals with obesity-related health risks, accompanied by recommended lifestyle changes.

A number of clinicians argue that, due to the significant potential of weight regain, the treatment is often long-term.

This perspective is echoed by drug manufacturers, who note that the findings "underscore the persistent nature of excess weight," comparing it to managing conditions like diabetes.

Patient Experiences

Individuals who have stopped the jabs explain a powerful return of hunger.

"It felt as if something that goes on and you become extremely hungry," described an individual.

This challenge is exacerbated if patients have not established lasting dietary or behavioural modifications during therapy.

Widespread Use

Recent estimates suggest that millions of adults in the UK have used these injections in the last 12 months, with desire remaining high.

  • Use is more common among females than males.
  • The middle-aged age group shows the highest usage rates.
  • A large proportion obtain the drugs through private prescriptions rather than public health services.

In conclusion, clinicians caution that while GLP-1 drugs are effective agents for weight loss, they are not a standalone cure and long-term success relies on combined lifestyle management.

By

Renee Greer

A seasoned gambling analyst with a passion for space-themed entertainment and betting trends.

Lunar Wager Daily

Type to search articles.